Works matching DE "NEUTRALIZATION tests"
Results: 765
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
- Published in:
- PLoS Medicine, 2021, v. 18, n. 10, p. 1, doi. 10.1371/journal.pmed.1003769
- By:
- Publication type:
- Article
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
GSK mRNA Flu Vaccine Candidate Delivers Favorable Topline Phase 2 Findings, Ready for Phase 3.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Dimeric ACE2-FC Is Equivalent to Monomeric ACE2 in the Surrogate Virus Neutralization Test.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 9, p. 1274, doi. 10.1134/S0006297923090079
- By:
- Publication type:
- Article
Einkünftekorrektur nach § 1 Abs. 1 AStG bei gewinnmindernder Ausbuchung sowie Teilwertabschreibung unbesicherter Forderungen aus Konzernlieferbeziehungen.
- Published in:
- FinanzRundschau, 2022, v. 104, n. 20, p. 962, doi. 10.9785/fr-2022-1042012
- Publication type:
- Article
СИЫР ШЕШЕГІНЕ ҚАРСЫ ЕГІЛГЕН ЖАНУАРЛАРДЫҢ ҚАН САРЫСУЫНАН ВИРУСТЫ БЕЙТАРАПТАУШЫ АНТИДЕНЕЛЕРДІ БЕЙТАРАПТАУ РЕАКЦИЯСЫНДА АНЫҚТАУ ҮШІН ВИРУСТЫҢ ТИІМДІ ДОЗАСЫН ТАҢДАУ.
- Published in:
- Eurasian Journal of Applied Biotechnology, 2024, n. 3, p. 84, doi. 10.11134/btp.3.2024.9
- By:
- Publication type:
- Article
重组产气荚膜梭菌毒素对家兔的安全性和免疫效力评价.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2023, v. 45, n. 4, p. 429, doi. 10.3969/j.issn.1008-0589.202212021
- By:
- Publication type:
- Article
检测鸡血清多杀性巴氏杆菌抗体的胶体金试纸条的 研制与应用.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2023, v. 45, n. 4, p. 374, doi. 10.3969/j.issn.1008-0589.202204026
- By:
- Publication type:
- Article
B亚型禽偏肺病毒灭活疫苗对商品肉鸡免疫效果的研究.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 10, p. 1071, doi. 10.3969/j.issn.1008-0589.202201033
- By:
- Publication type:
- Article
鹅星状病毒衣壳蛋白间接 ELISA 检测方法的建立.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 8, p. 850, doi. 10.3969/j.issn.1008-0589.202112001
- By:
- Publication type:
- Article
猪圆环病毒2 型病毒样颗粒和塞内卡病毒 灭活二联疫苗免疫效力实验.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 4, p. 411, doi. 10.3969/j.issn.1008-0589.202102011
- By:
- Publication type:
- Article
Operation Nasal Vaccine—Lightning speed to counter COVID-19.
- Published in:
- Science Immunology, 2022, v. 7, n. 74, p. 1, doi. 10.1126/sciimmunol.add9947
- By:
- Publication type:
- Article
The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages.
- Published in:
- Antibiotics (2079-6382), 2025, v. 14, n. 1, p. 87, doi. 10.3390/antibiotics14010087
- By:
- Publication type:
- Article
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 27, doi. 10.3390/vaccines13010027
- By:
- Publication type:
- Article
Differential Neutralization Profiles of 17DD Vaccinated Population to 17D-204 and 17DD Vaccine Strains.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1311, doi. 10.3390/vaccines12121311
- By:
- Publication type:
- Article
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1099, doi. 10.3390/vaccines12101099
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1001, doi. 10.3390/vaccines12091001
- By:
- Publication type:
- Article
Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 827, doi. 10.3390/vaccines12080827
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 683, doi. 10.3390/vaccines12060683
- By:
- Publication type:
- Article
Accuracy of Anti-SARS-CoV-2 Antibody in Comparison with Surrogate Viral Neutralization Test in Persons Living with HIV, Systemic Lupus Erythematosus, and Chronic Kidney Disease.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 558, doi. 10.3390/vaccines12050558
- By:
- Publication type:
- Article
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 554, doi. 10.3390/vaccines12050554
- By:
- Publication type:
- Article
Questionable Immunity to Mumps among Healthcare Workers in Italy—A Cross-Sectional Serological Study.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 522, doi. 10.3390/vaccines12050522
- By:
- Publication type:
- Article
Antibody Response against SARS-CoV-2 after mRNA Vaccine in a Cohort of Hospital Healthy Workers Followed for 17 Months.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 506, doi. 10.3390/vaccines12050506
- By:
- Publication type:
- Article
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac ® and ChAdOx1-S Vaccines for SARS-CoV-2.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 344, doi. 10.3390/vaccines12040344
- By:
- Publication type:
- Article
Long-Term Immunological Alertness and Response to COVID-19 Vaccination—Conditions for Prevention in Early Palliative Oncological Care Patients.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 299, doi. 10.3390/vaccines12030299
- By:
- Publication type:
- Article
Evaluation of Two Vaccines against Foot-and-Mouth Disease Used in Transcaucasian Countries by Small-Scale Immunogenicity Studies Conducted in Georgia, Azerbaijan and Armenia.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 295, doi. 10.3390/vaccines12030295
- By:
- Publication type:
- Article
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 94, doi. 10.3390/vaccines12010094
- By:
- Publication type:
- Article
Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 76, doi. 10.3390/vaccines12010076
- By:
- Publication type:
- Article
The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1815, doi. 10.3390/vaccines11121815
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1798, doi. 10.3390/vaccines11121798
- By:
- Publication type:
- Article
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1644, doi. 10.3390/vaccines11111644
- By:
- Publication type:
- Article
Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1586, doi. 10.3390/vaccines11101586
- By:
- Publication type:
- Article
Does Perioperative Administration of Rabies Vaccine in Dogs Undergoing Surgical Sterilization Induce an Adequate Antibody Response?
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1418, doi. 10.3390/vaccines11091418
- By:
- Publication type:
- Article
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1329, doi. 10.3390/vaccines11081329
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1311, doi. 10.3390/vaccines11081311
- By:
- Publication type:
- Article
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1234, doi. 10.3390/vaccines11071234
- By:
- Publication type:
- Article
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1161, doi. 10.3390/vaccines11071161
- By:
- Publication type:
- Article
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6–7 Months: A Phase 4, Randomized, Controlled Trial.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 862, doi. 10.3390/vaccines11040862
- By:
- Publication type:
- Article
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 723, doi. 10.3390/vaccines11040723
- By:
- Publication type:
- Article
Longitudinal Profiles of Anti-Platelet Factor 4 Antibodies in Thai People Who Received ChAdOx1 nCoV-19 Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 692, doi. 10.3390/vaccines11030692
- By:
- Publication type:
- Article
Neutralization Effect of Sera against Delta and Omicron in Patients Recovering from COVID-19 and Inactivated Vaccine Recipients.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 471, doi. 10.3390/vaccines11020471
- By:
- Publication type:
- Article
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 455, doi. 10.3390/vaccines11020455
- By:
- Publication type:
- Article
Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 376, doi. 10.3390/vaccines11020376
- By:
- Publication type:
- Article
One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 355, doi. 10.3390/vaccines11020355
- By:
- Publication type:
- Article
Lack of Evidence on Association between Iron Deficiency and COVID-19 Vaccine-Induced Neutralizing Humoral Immunity.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 327, doi. 10.3390/vaccines11020327
- By:
- Publication type:
- Article
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 326, doi. 10.3390/vaccines11020326
- By:
- Publication type:
- Article
Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 299, doi. 10.3390/vaccines11020299
- By:
- Publication type:
- Article
A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 128, doi. 10.3390/vaccines11010128
- By:
- Publication type:
- Article
Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 73, doi. 10.3390/vaccines11010073
- By:
- Publication type:
- Article
Serum Metabolic Correlates of the Antibody Response in Subjects Receiving the Inactivated COVID-19 Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1890, doi. 10.3390/vaccines10111890
- By:
- Publication type:
- Article